Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitonin added to bupivacaine for erector spinae plane block in mastectomy pain
IRCT20220212054002N1Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Apr 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, double-blind trial of TBRIA and bupivacaine in acute postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoints: First rescue analgesia request, Total opioid requirement and 1 more. Started Apr 2022; status: completed.
02
Drugs
TBRIAbupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on IRCT20220212054002N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220212054002N1.